• Online Features  This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (88)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Platelet 2-Adrenergic Receptor Binding and Plasma Catecholamines

Before and During Imipramine Treatment in Patients With Panic Anxiety

Oliver G. Cameron, MD, PhD; Charles B. Smith, MD, PhD; Peggie J. Hollingsworth, PhD; Randolph M. Nesse, MD; George C. Curtis, MD

Arch Gen Psychiatry. 1984;41(12):1144-1148.

Abstract

• Specific binding of tritiated clonidine, an 2-adrenergic receptor agonist, and tritiated yohimbine, an 2-adrenergic receptor antagonist, to platelet membranes was measured in persons with panic attacks or major depression and in normal subjects. Plasma catecholamine levels were measured in patients with panic attacks and in normal subjects. The number of binding sites in patients with panic attacks, as measured with tritiated clonidine, was lower than in depressed persons and was the same as in normal subjects. The number in patients with panic attacks, as measured with tritiated yohimbine, was lower than in either depressives or normal subjects. Catecholamine levels were somewhat higher in patients with panic attacks than in normal subjects. Treatment with imipramine hydrochloride decreased the number of sites, as measured with either ligand, in both patient groups and increased catecholamine levels in patients with panic attacks.

Author Affiliations

Footnotes

Read in part before the annual meeting of the American Psychiatric Association, New York City, May 4, 1983.

Reprint requests to Department of Pharmacology, University of Michigan, Ann Arbor, MI 48109 (Dr Smith).

CiteULike    Connotea    Delicious    Digg    Facebook    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The role of central noradrenergic dysregulation in anxiety disorders: evidence from clinical studies
Kalk et al.
J Psychopharmacol 2011;25:3-16.
ABSTRACT  

Sympathetic Nervous System Activity in Major Depression: Basal and Desipramine-Induced Alterations in Plasma Norepinephrine Kinetics
Veith et al.
Arch Gen Psychiatry 1994;51:411-422.
ABSTRACT  

The Significance of Low Serum Thyrotropin in the Elderly
Serjeant
Arch Intern Med 1991;151:2318-2318.
ABSTRACT  

Desipramine Lowers Tritiated Para-Aminoclonidine Binding in Platelets of Depressed Patients
Piletz et al.
Arch Gen Psychiatry 1991;48:813-820.
ABSTRACT  

Imipramine in panic disorder. 2. Effects on {alpha}2-adrenoceptor function
Nutt and Glue
J Psychopharmacol 1991;5:135-141.
ABSTRACT  

Clonidine challenge testing of alpha-2-adrenoceptor function in man: the effects of mental illness and psychotropic medication
Glue et al.
J Psychopharmacol 1988;2:119-137.
ABSTRACT  

Abnormal Regulation of Noradrenergic Function in Panic Disorders: Effects of Clonidine in Healthy Subjects and Patients With Agoraphobia and Panic Disorder
Charney and Heninger
Arch Gen Psychiatry 1986;43:1042-1054.
ABSTRACT  

Platelet {alpha}2-Adrenergic Receptors in Depression
Kafka and Paul
Arch Gen Psychiatry 1986;43:91-95.
ABSTRACT